(Total Views: 613)
Posted On: 06/03/2020 7:42:28 PM
Post# of 153963
My own catalyst list, for anyone who might be interested:
POTENTIAL CATALYSTS w / Estimated Dates
- Exchange Uplist Update (1-2 Weeks)
- Mexico COVID P3 Severe-Critical Protocol (1-2 Weeks)
- Amarex Monte/Ga NEJM Submissions (1-2 Weeks)
- US COVID P2 Mild-Moderate Stop/Unblind (2 Weeks)
- Investment Bank Update (1-4 Weeks)
- US COVID Distribution Update (1-4 Weeks)
- Dr.BP Manuscript #1 Peer Review (1-4 Weeks)
- Dr.BP Infectious Virus in Plasma Update (1-4 Weeks)
- Dr.BP Rantes Susceptibility Testing Program Update (1-4 Weeks)
- Dr.SK Science Advisory Board Update (1-4 Weeks)
- Commercialization Officer Hire Update (1-4 Weeks)
- Mexico COVID P3 Severe-Critical Fully Enrolled (2-4 Weeks)
- US FDA Combo HIV BLA Accept?/ PDUFA Date (2-4 Weeks)
- US COVID P2 Mild-Moderate Results (4-6 Weeks)
- US COVID P3 Severe-Critical Interim Results (4-6 Weeks)
- Samsung Biologics First Shipments Arrive (4-6 Weeks)
- Dr.BP Manuscript #2 Pre-Print (4-8 Weeks)
- Mexico COVID P3 Severe-Critical Interim Results (6-8 Weeks)
- US COVID Grants / Funding Update (6-8 Weeks)
- US COVID P2 Mild-Moderate Approval Ruling (6-8 Weeks)
- US COVID P3 Severe-Critical Interim Approval Ruling (6-8 Weeks)
- Mexico COVID P3 Severe-Critical Approval Ruling (8-10 Weeks)
- Dr.BP Manuscript #2 Peer Review (8-12 Weeks)
- US FDA BTD mTNBC Meeting Update (8-12 Weeks)
- Cancer Licensing/Partnership Update (6-Companies) (8-12 Weeks)
- COVID Licensing/Partnership Update (5-Companies) (8-12 Weeks)
- HIV Licensing/Partnership Update (2-Companies) (8-12 Weeks)
- Dr. Sacha HIV PrEP Paper (8-12 Weeks)
- US Cancer Basket Trial Update (8-12 Weeks)
- Taiwan Cancer Basket Trial Update (8-12 Weeks)
- US FDA Combo HIV Approval? (3-6 Months)
- US P3 Mono HIV Trial Update (3-6 Months)
- US P2 Assorted Trials Total=10 (3-6 Months)
COMPLETED
- Dr.BP Manuscript #1 Pre-print Published
- US COVID Pediatric Protocol Available
BACK-BURNER
- UK / Ireland Emergency Trial
- US COVID P3 Remdesivir 3-Arm Trial
REJECTED
- US COVID Compassionate Use (EUA)
POTENTIAL CATALYSTS w / Estimated Dates
- Exchange Uplist Update (1-2 Weeks)
- Mexico COVID P3 Severe-Critical Protocol (1-2 Weeks)
- Amarex Monte/Ga NEJM Submissions (1-2 Weeks)
- US COVID P2 Mild-Moderate Stop/Unblind (2 Weeks)
- Investment Bank Update (1-4 Weeks)
- US COVID Distribution Update (1-4 Weeks)
- Dr.BP Manuscript #1 Peer Review (1-4 Weeks)
- Dr.BP Infectious Virus in Plasma Update (1-4 Weeks)
- Dr.BP Rantes Susceptibility Testing Program Update (1-4 Weeks)
- Dr.SK Science Advisory Board Update (1-4 Weeks)
- Commercialization Officer Hire Update (1-4 Weeks)
- Mexico COVID P3 Severe-Critical Fully Enrolled (2-4 Weeks)
- US FDA Combo HIV BLA Accept?/ PDUFA Date (2-4 Weeks)
- US COVID P2 Mild-Moderate Results (4-6 Weeks)
- US COVID P3 Severe-Critical Interim Results (4-6 Weeks)
- Samsung Biologics First Shipments Arrive (4-6 Weeks)
- Dr.BP Manuscript #2 Pre-Print (4-8 Weeks)
- Mexico COVID P3 Severe-Critical Interim Results (6-8 Weeks)
- US COVID Grants / Funding Update (6-8 Weeks)
- US COVID P2 Mild-Moderate Approval Ruling (6-8 Weeks)
- US COVID P3 Severe-Critical Interim Approval Ruling (6-8 Weeks)
- Mexico COVID P3 Severe-Critical Approval Ruling (8-10 Weeks)
- Dr.BP Manuscript #2 Peer Review (8-12 Weeks)
- US FDA BTD mTNBC Meeting Update (8-12 Weeks)
- Cancer Licensing/Partnership Update (6-Companies) (8-12 Weeks)
- COVID Licensing/Partnership Update (5-Companies) (8-12 Weeks)
- HIV Licensing/Partnership Update (2-Companies) (8-12 Weeks)
- Dr. Sacha HIV PrEP Paper (8-12 Weeks)
- US Cancer Basket Trial Update (8-12 Weeks)
- Taiwan Cancer Basket Trial Update (8-12 Weeks)
- US FDA Combo HIV Approval? (3-6 Months)
- US P3 Mono HIV Trial Update (3-6 Months)
- US P2 Assorted Trials Total=10 (3-6 Months)
COMPLETED
- Dr.BP Manuscript #1 Pre-print Published
- US COVID Pediatric Protocol Available
BACK-BURNER
- UK / Ireland Emergency Trial
- US COVID P3 Remdesivir 3-Arm Trial
REJECTED
- US COVID Compassionate Use (EUA)
(8)
(0)
